Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea · Delayed Price · Currency is KRW 15,410
+280 (1.85%)
Sep 1, 2026, 3:30 PM KST
Anterogen.Co.,Ltd. Market Cap
Anterogen.Co.,Ltd. has a market cap or net worth of 151.39 billion as of September 1, 2026. Its market cap has decreased by -39.24% in one year.
Market Cap
151.39B
Enterprise Value
108.71B
Revenue
8.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
15,410.00
ChartMarket Cap Chart
Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has decreased from 291.82B to 151.39B, a decrease of -48.12%. That is a compound annual growth rate of -6.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 151.39B | -67.71% |
| Dec 30, 2025 | 468.79B | 155.02% |
| Dec 30, 2024 | 183.83B | 10.53% |
| Dec 28, 2023 | 166.31B | 16.26% |
| Dec 29, 2022 | 143.05B | -76.39% |
| Dec 30, 2021 | 605.82B | 6.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoImmuneTech | 248.16B |
| Bioneer | 214.48B |
| GC Cell | 202.72B |
| HLB Therapeutics | 196.24B |
| GC Genome | 141.20B |
| Helixmith | 138.14B |
| Genexine | 124.39B |
| MedPacto | 93.91B |